Should we abandon the APTT for monitoring unfractionated heparin?-Reference-Cited by-同舟云学术

Should we abandon the APTT for monitoring unfractionated heparin?

Published:2017-09 Issue: Volume:157 Page:157-161
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Arachchillage D.R.J.,Kamani F.,Deplano S.,Banya W.,Laffan M.

Publisher

Elsevier BV

Subject

Hematology

Reference27 articles.

1. Heparin overview and issues;Bussey;Pharmacotherapy,2004

2. Monitoring unfractionated heparin with the aPTT: time for a fresh look;Eikelboom;Thromb. Haemost.,2006

3. Induction of the acute-phase reaction increases heparin-binding proteins in plasma;Young;Arterioscler. Thromb. Vasc. Biol.,1997

4. The binding of unfractionated heparin and low molecular weight heparin to thrombin-activated human endothelial cells;Young;Thromb. Res.,1999

5. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy;Olson;Arch. Pathol. Lab. Med.,1998

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory Monitoring of Heparin Anticoagulation in Hemodialysis: Rationale and Strategies;Seminars in Nephrology;2024-01

2. Extracorporeal membrane oxygenation and other extracorporeal devices;Hemostasis Management of the Pediatric Surgical Patient;2024

3. Chromogenic and Clot-Based Bivalirudin Assays for Monitoring Anticoagulation;The Journal of Applied Laboratory Medicine;2023-10-09

4. Anti-Xa testing for pediatric and neonatal patients on extracorporeal membrane oxygenation;Perfusion;2023-06-20

5. Factors Influencing Anti-Xa Assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin;Thrombosis and Haemostasis;2023-06-15